POSEIDA THERAPEUTICSCS INC
Action · US73730P1084 · PSTX · A2PEYK (XNAS)
Pas de cours
n/a
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
- | - | 0,00 % | 0,00 % | 1,92 % | 244,40 % | -37,85 % |
Profil de l'entreprise pour POSEIDA THERAPEUTICSCS INC Action
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
Fonds investis
Les fonds suivants ont investi dans : POSEIDA THERAPEUTICSCS INC investi :
Fonds | Vol. en millions 16,28 | Part (%) 0,04 % |
Données de l'entreprise
Nom POSEIDA THERAPEUTICSCS INC
Société Poseida Therapeutics, Inc.
Symbole PSTX
Site web
https://www.poseida.com
Marché d'origine
NASDAQ

WKN A2PEYK
ISIN US73730P1084
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Mark J. Gergen J.D.
Capitalisation boursière 926 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,4 T
Adresse 9390 Towne Centre Drive, 92121 San Diego
Date d'introduction en bourse 2020-07-10
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | 2RZ.F |
NASDAQ | PSTX |
Autres actions
Les investisseurs qui détiennent POSEIDA THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.